The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness and safety of first-line (1L) avelumab + axitinib in patients with advanced renal cell carcinoma (aRCC): Primary analysis of the AVION study.
 
Axel Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen-Cilag; MSD Oncology; Takeda
Speakers' Bureau - Ipsen; Johnson & Johnson/Janssen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag
 
Olga Baklanova
Consulting or Advisory Role - Eisai
Research Funding - Merck KGaA; Pfizer; Roche
 
Victor Garlonta
Consulting or Advisory Role - Apogepha; Merck KGaA
 
Nikolaos Androulakis
Consulting or Advisory Role - Astellas Pharma; Bayer; Genesis Pharma; Janssen; Merck; Merck KGaA; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Genesis Pharma; Janssen; Merck; Merck KGaA; Novartis; Pfizer
 
Athina Christopoulou
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche; Sanofi
 
Eleni Timotheadou
Consulting or Advisory Role - AstraZeneca; Genesis Pharmaceuticals; GlaxoSmithKline; Integris; Merck KGaA; Pfizer; Pierre Fabre; Teva
Research Funding - Merck KGaA
Other Relationship - AstraZeneca; GlaxoSmithKline
 
Wim Demey
Consulting or Advisory Role - Merck KGaA; Pfizer
 
Jan Janssen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck KGaA; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Novartis; Octapharm; Onkovis
 
Philipp Ivanyi
Stock and Other Ownership Interests - BB Biotech Ventures
Honoraria - AIMM Therapeutics; AstraZeneca; Bayer/Vital; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Roche Pharma AG
Consulting or Advisory Role - Bayer/Vital; Bristol-Myers Squibb; ClinSol; Deciphera; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Merck Serono
Other Relationship - Merck Serono; Pfizer
(OPTIONAL) Uncompensated Relationships - AIO-Studien; German Cancer Society
 
Barbara Brouwers
Speakers' Bureau - Ipsen; Merck
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Merck KGaA; Pfizer; Roche
 
Wim Wynendaele
Consulting or Advisory Role - Janssen; Novartis; Pfizer; Roche
Speakers' Bureau - Janssen; Novartis; Pfizer; Roche
 
Lusha Wang
Employment - Merck Serono Co., Ltd., Beijing, China, an affiliate of Merck KGaA, Darmstadt, Germany
 
Lenka Kostkova
Employment - Merck spol. s r.o., Bratislava, Slovakia, an affiliate of Merck KGaA, Darmstadt, Germany
 
Jason Hoffman
Employment - EMD Serono
Stock and Other Ownership Interests - Merck; Merck & Co., Kenilworth, NJ, USA; Pfizer
 
Arndt Manzel
Employment - Merck KGaA
 
Anna Koumarianou
Honoraria - Pfizer
Consulting or Advisory Role - Genesis Pharma
Speakers' Bureau - Roche
Research Funding - Bristol-Myers Squibb; Genesis Pharmaceuticals; Ipsen; Merck; Merck KGaA; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - fees from Merck & Co., Kenilworth, NJ